共 50 条
- [21] Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trialLANCET NEUROLOGY, 2017, 16 (03): : 208 - 216Meininger, VincentGenge, Angelavan den Berg, Leonard H.Robberecht, WimLudolph, AlbertChio, AdrianoKim, Seung H.Leigh, P. NigelKiernan, Matthew C.Shefner, Jeremy M.Desnuelle, ClaudeMorrison, Karen E.Petri, SusanneBoswell, DianeTemple, JaneMohindra, RajatDavies, MattBullman, JonathanRees, PaulLavrov, Arseniy
- [22] Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trialBRAIN BEHAVIOR AND IMMUNITY, 2025, 123 : 177 - 184Leboyer, MarionFoiselle, MarianneTchitchek, NicolasTamouza, RyadLorenzon, RobertaRichard, Jean-RomainArrouasse, RaphaeleLe Corvoisier, PhilippeLe Dudal, KatiaVicaut, EricEllul, PierreRosenzwajg, MichelleKlatzmann, David
- [23] Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)ECLINICALMEDICINE, 2022, 46Hernandez-Bernal, FranciscoRicardo-Cobas, Maria C.Martin-Bauta, YenimaNavarro-Rodriguez, ZadisPinera-Martinez, MarjorisQuintana-Guerra, JoelUrrutia-Perez, KarenUrrutia-Perez, KlaudiaChavez-Chong, Cristina O.Azor-Hernandez, Jorge L.Rodriguez-Reinoso, Jose L.Lobaina-Lambert, LeonardoColina-Avila, ElizabethBizet-Almeida, JacquelineRodriguez-Nuviola, Jenifferdel Valle-Pinera, SergioRamirez-Dominguez, MayaraTablada-Ferreiro, ElisangelaAlonso-Valdes, MarelLemos-Perez, GildaGuillen-Nieto, Gerardo E.Palenzuela-Diaz, ArielNoa-Romero, EnriqueLimonta-Fernandez, MiladysFernandez-Avila, Juan M.Ali-Mros, Nabil A.del Toro-Lahera, LianneRemedios-Reyes, RossanaAyala-Avila, MartaMuzio-Gonzalez, Verena L.
- [25] Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialLANCET, 2019, 394 (10208): : 1540 - 1550Agarwal, RajivRossignol, PatrickRomero, AlainGarza, DahliaMayo, Martha R.Warren, SuzetteMa, JiaWhite, William B.Williams, Bryan
- [26] Study protocol for assessment of the efficacy of calcium dobesilate versus placebo on SARS-CoV-2 viral load in outpatients with COVID-19 (CADOVID study): a randomised, placebo-controlled, double-blind, monocentric phase II trialBMJ OPEN, 2024, 14 (05):Salamun, JulienDa Silva, TamaraUstero, PilarGosmain, YvanGuessous, IdrisCalmy, AlexandraSpechbach, Herve
- [27] Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialLANCET INFECTIOUS DISEASES, 2021, 21 (10): : 1383 - 1394Chappell, Keith J.Mordant, Francesca L.Li, ZheyiWijesundara, Danushka K.Ellenberg, PaulaLackenby, Julia A.Cheung, Stacey T. M.Modhiran, NaphakAvumegah, Michael S.Henderson, Christina L.Hoger, KymGriffin, PaulBennet, JillianHensen, LucaZhang, WujiNguyen, Thi H. O.Marrero-Hernandez, SaraSelva, Kevin J.Chung, Amy W.Tran, Mai H.Tapley, PeterBarnes, JamesReading, Patrick C.Nicholson, SuellenCorby, StavroulaHolgate, ThomasWines, Bruce D.Hogarth, P. MarkKedzierska, KatherinePurcell, Damian F. J.Ranasinghe, CharaniSubbarao, KantaWatterson, DanielYoung, Paul R.Munro, Trent P.
- [28] Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in TurkeyLANCET, 2021, 398 (10296): : 213 - 222Tanriover, Mine DurusuDoganay, Hamdi LeventAkova, MuratGuner, Hatice RahmetAzap, AlpayAkhan, SilaKose, SukranErdinc, Fatma SebnemAkalin, Emin HalisTabak, Omer FehmiPullukcu, HusnuBatum, OzgurYavuz, Serap SimsekTurhan, OzgeYildirmak, Mustafa TanerKoksal, IftiharTasova, YesimKorten, VolkanYilmaz, GurdalCelen, Mustafa KemalAltin, SedatCelik, IlhamiBayindir, YasarKaraoglan, IlkayYilmaz, AydinOzkul, AykutGur, HazalUnal, Serhat
- [29] Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trialLANCET, 2021, 397 (10268): : 51 - 60Croop, RobertLipton, Richard B.Kudrow, DavidStock, David A.Kamen, LisaConway, Charles M.Stock, Elyse G.Coric, VladimirGoadsby, Peter J.
- [30] Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) : 653 - 661Cid, Maria C.Unizony, Sebastian H.Blockmans, DanielBrouwer, ElisabethDagna, LorenzoDasgupta, BhaskarHellmich, BernhardMolloy, EamonnSalvarani, CarloTrapnell, Bruce C.Warrington, Kenneth J.Wicks, IanSamant, ManojZhou, TeresaPupim, LaraPaolini, John F.